<<

VITEK®2 Gram-negative Susceptibility Panels

REDUCE YOUR OFF-LINE TESTING Enhance your antimicrobial susceptibility testing solution with drug formulations to help positively impact patient care. Introducing AST-XN09, our flexible extension panel, with / and ceftolozane/.

GRAM-NEGATIVE EXTENSION PANEL REF 421982 – AST-GN95 REF 423425 - AST-XN09 REF 423102 – AST-GN99 SOFTWARE VERSION REQUIRED: 7.01 SOFTWARE VERSION REQUIRED: 9 SOFTWARE VERSION REQUIRED: 7.01

ANTIMICROBIAL MIC CALLING ANTIMICROBIAL MIC CALLING ANTIMICROBIAL MIC CALLING AGENT RANGE (μg/mL) AGENT RANGE (μg/mL) AGENT RANGE (μg/mL) 2-32 Amikacin 2-64 / 2/1-32/16 Ampicillin/ 2/1-32/16 1-64 Ampicillin 2-32 4-64 2-64 Cefazolin 4 - 64 * 0.12-32 * 0.25-64 Cefepime* 0.12 - 32 Ceftazidime 1-64 4-64 * 0.25 - 64 Ceftriaxone* 0.25-64 4-64 1 - 64 Ciprofloxacin 0.25-4 0.25-8 Ciprofloxacin 0.25 - 4 * 0.12-8 Ceftolozane/ Tazobactam 0.25-32 Ertapenem* 0.12 - 8 ESBL Confirm NEG/POS Cefuroxime 1-64 Gentamicin 1 - 16 Gentamicin 1-16 Ceftazidime/ 0.25 - 16 Imipenem 0.25-16 Avibactam 0.12-16 Levofloxacin 0.12 - 8 Levofloxacin 0.12-8 0.25-16 Meropenem 0.25 - 16 Nitrofurantoin 16-512 Moxifloxacin 0.25-8 Nitrofurantoin 16 - 512 / Tazobactam 4/4-128/4 Nalidixic Acid 2-32 Piperacillin/ 4/4 - 128/4 Tetracycline 1-16 Tazobactam Tobramycin 1-16 /Clav. Acid 8/2-128/2 Tetracycline 1-16 20(1/19)- Trimethoprim/Sulfa 320(16/304) Tigecycline† 0.5-8 Tobramycin 1-16 20 (1/19) - Use AST-GN95 and AST-XN09 together to reduce off-line testing. Trimethoprim/Sulfa 320 (16/304)

*Reformulated – Lower Breakpoints †Reformulated VITEK® 2 PANELS: FERMENTER AND NON-FERMENTER • Seven reformulated antimicrobial agents • Lower breakpoints for cefepime, cefotaxime, and ciprofloxacin • Enhance your antimicrobial stewardship program with same-day susceptibilities

FERMENTER PANEL NON-FERMENTER PANEL MIC CALLING ANTIMICROBIAL AGENT REF 423310 - AST-N800* REF 423416 - AST-N801 RANGE (μg/mL) SOFTWARE VERSION SOFTWARE VERSION REQUIRED: 9.01 REQUIRED: 8.01

Amikacin† 1 - 64 x Amoxicilin/Clav. Acid 2/1 - 32/16 x Ampicilin/Sulbactam 2/1 - 32/16 x Aztreonam 1 - 64 x Cefazolin 4 - 64 x Cefepime‡ 0.12 - 32 x x Cefotaxime‡ 0.25 - 64 x Cefoxitin 4 - 64 x Ceftazidime 1 - 64 x x Ceftazidime/Avibactam 0.12 - 16 x Ceftolozane/Tazobactam 0.25 - 32 x Ciprofloxacin‡ 0.06 - 4 x x Gentamicin† 1 - 16 x x Imipenem 0.25 - 16 x x Levofloxacin 0.12 - 8 x x Meropenem 0.25 - 16 x x Nitrofurantoin 16 - 512 x Piperacilin/Tazobactam 4/4 - 128/4 x x Tetracycline 1 - 16 x x Tigecycline† 0.5 - 8 x Tobramycin† 1 - 16 x Trimethoprim/Sulfa 20(1/19) - 320 (16/304) x x

*Deduce ceftriaxone based on cefotaxime †Reformulated ‡Reformulated- Lower Breakpoints Order reagents and track shipments: www.biomerieuxDIRECT.com

For more information, contact your local bioMérieux representative. • www.biomerieux-usa.com/vitek

bioMérieux, Inc. • 100 Rodolphe Street • Durham, NC 27712 • USA • Tel: (800) 682 2666 • Fax: (800) 968 9494

©2019 bioMérieux, Inc. • BIOMERIEUX and the BIOMERIEUX logo, and VITEK, are used pending and/or registered trademarks belonging to bioMérieux, or bioMérieux, belonging to trademarks registered pending and/or used are VITEK, and logo, and the BIOMERIEUX • BIOMERIEUX Inc. bioMérieux, ©2019 02.A - Rev • PRN: 052569 www.biomerieux-usa.com/patents • Patents: companies its or one of subsidiaries, its one of www.biomerieux-usa.com